Lumos Diagnostics Holdings Limited (ASX:LDX)
Australia flag Australia · Delayed Price · Currency is AUD
0.0280
+0.0020 (7.69%)
May 14, 2025, 4:10 PM AEST

ASX:LDX Revenue

Lumos Diagnostics Holdings had revenue of $6.31M USD in the half year ending December 31, 2024, with 23.96% growth. This brings the company's revenue in the last twelve months to $14.67M, up 78.61% year-over-year. In the fiscal year ending June 30, 2024, Lumos Diagnostics Holdings had annual revenue of $11.13M with 5.66% growth.

Revenue (ttm)
$14.67M
Revenue Growth
+78.61%
P/S Ratio
0.82
Revenue / Employee
n/a
Employees
n/a
Market Cap
19.46M AUD

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Jun 30, 202411.13M596.00K5.66%
Jun 30, 202310.54M-1.10M-9.42%
Jun 30, 202211.63M-7.22M-38.32%
Jun 30, 202118.85M13.06M225.25%
Jun 30, 20205.80M1.32M29.54%
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
CSL Limited 24.61B
Pro Medicus 184.58M
Cochlear 2.31B
Sonic Healthcare 9.33B
Ramsay Health Care 17.12B
Telix Pharmaceuticals 783.21M
Ansell 3.00B
Regis Healthcare 1.10B
Revenue Rankings